HeadInvest LLC’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.34M | Buy |
9,300
+55
| +0.6% | +$11.8K | 0.44% | 63 |
|
|
2026
Q1 | $2.01M | Sell |
9,245
-287
| -3% | -$63.7K | 0.41% | 61 |
|
|
2025
Q4 | $2.18M | Buy |
9,532
+1,129
| +13% | +$257K | 0.43% | 61 |
|
|
2025
Q3 | $1.95M | Buy |
8,403
+288
| +4% | +$58.6K | 0.4% | 62 |
|
|
2025
Q2 | $1.51M | Sell |
8,115
-1,231
| -13% | -$229K | 0.32% | 65 |
|
|
2025
Q1 | $1.96M | Sell |
9,346
-354
| -4% | -$68.8K | 0.38% | 63 |
|
|
2024
Q4 | $1.72M | Sell |
9,700
-211
| -2% | -$38.8K | 0.33% | 71 |
|
|
2024
Q3 | $1.96M | Sell |
9,911
-134
| -1% | -$25K | 0.36% | 66 |
|
|
2024
Q2 | $1.72M | Sell |
10,045
-327
| -3% | -$54.2K | 0.34% | 66 |
|
|
2024
Q1 | $1.89M | Sell |
10,372
-435
| -4% | -$75K | 0.37% | 61 |
|
|
2023
Q4 | $1.67M | Sell |
10,807
-770
| -7% | -$112K | 0.35% | 65 |
|
|
2023
Q3 | $1.72M | Sell |
11,577
-996
| -8% | -$146K | 0.37% | 63 |
|
|
2023
Q2 | $1.91M | Sell |
12,573
-1,030
| -8% | -$151K | 0.41% | 53 |
|
|
2023
Q1 | $2.17M | Sell |
13,603
-781
| -5% | -$119K | 0.48% | 50 |
|
|
2022
Q4 | $2.32M | Sell |
14,384
-28
| -0.2% | -$4.29K | 0.52% | 49 |
|
|
2022
Q3 | $1.93M | Buy |
14,412
+73
| +0.5% | +$10.5K | 0.46% | 54 |
|
|
2022
Q2 | $2.2M | Sell |
14,339
-39
| -0.3% | -$5.96K | 0.49% | 53 |
|
|
2022
Q1 | $2.33M | Buy |
14,378
+148
| +1% | +$21.5K | 0.45% | 51 |
|
|
2021
Q4 | $1.93M | Buy |
14,230
+370
| +3% | +$43.7K | 0.34% | 63 |
|
|
2021
Q3 | $1.5M | Buy |
13,860
+122
| +0.9% | +$13.9K | 0.28% | 66 |
|
|
2021
Q2 | $1.55M | Buy |
13,738
+161
| +1% | +$18.1K | 0.29% | 66 |
|
|
2021
Q1 | $1.47M | Buy |
13,577
+1,395
| +11% | +$149K | 0.3% | 65 |
|
|
2020
Q4 | $1.3M | Buy |
12,182
+1,928
| +19% | +$185K | 0.28% | 69 |
|
|
2020
Q3 | $898K | Buy |
10,254
+1,125
| +12% | +$106K | 0.26% | 72 |
|
|
2020
Q2 | $896K | Buy |
9,129
+369
| +4% | +$32.5K | 0.28% | 66 |
|
|
2020
Q1 | $667K | Buy |
8,760
+189
| +2% | +$16.1K | 0.25% | 72 |
|
|
2019
Q4 | $759K | Buy |
8,571
+30
| +0.4% | +$2.49K | 0.22% | 78 |
|
|
2019
Q3 | $647K | Buy |
8,541
+1,732
| +25% | +$119K | 0.2% | 82 |
|
|
2019
Q2 | $495K | Buy |
6,809
+160
| +2% | +$12.6K | 0.14% | 105 |
|
|
2019
Q1 | $536K | Sell |
6,649
-6,649
| -50% | -$544K | 0.15% | 102 |
|
|
2018
Q4 | $1.23M | Buy |
13,298
+6,629
| +99% | +$583K | 0.19% | 83 |
|
|
2018
Q3 | $631K | Sell |
6,669
-108
| -2% | -$10.2K | 0.18% | 85 |
|
|
2018
Q2 | $628K | Buy |
6,777
+20
| +0.3% | +$1.95K | 0.19% | 85 |
|
|
2018
Q1 | $640K | Sell |
6,757
-450
| -6% | -$49.4K | 0.21% | 79 |
|
|
2017
Q4 | $697K | Sell |
7,207
-200
| -3% | -$18.8K | 0.22% | 80 |
|
|
2017
Q3 | $668K | Buy |
7,407
+1,075
| +17% | +$81.8K | 0.21% | 83 |
|
|
2017
Q2 | $459K | Buy |
6,332
+150
| +2% | +$10.1K | 0.15% | 93 |
|
|
2017
Q1 | $403K | Buy |
6,182
+400
| +7% | +$25.1K | 0.14% | 100 |
|
|
2016
Q4 | $362K | Hold |
5,782
| – | – | 0.13% | 101 |
|
|
2016
Q3 | $366K | Hold |
5,782
| – | – | 0.13% | 102 |
|
|
2016
Q2 | $358K | Sell |
5,782
-100
| -2% | -$6.09K | 0.14% | 92 |
|
|
2016
Q1 | $336K | Hold |
5,882
| – | – | 0.13% | 96 |
|
|
2015
Q4 | $348K | Hold |
5,882
| – | – | 0.14% | 91 |
|
|
2015
Q3 | $320K | Sell |
5,882
-983
| -14% | -$64K | 0.13% | 93 |
|
|
2015
Q2 | $461K | Buy |
6,865
+50
| +0.7% | +$3.26K | 0.17% | 82 |
|
|
2015
Q1 | $399K | Hold |
6,815
| – | – | 0.14% | 85 |
|
|
2014
Q4 | $446K | Hold |
6,815
| – | – | 0.18% | 75 |
|
|
2014
Q3 | $432K | Buy |
6,815
+1,074
| +19% | +$59.6K | 0.17% | 76 |
|
|
2014
Q2 | $324K | Hold |
5,741
| – | – | 0.13% | 88 |
|
|
2014
Q1 | $295K | Buy |
5,741
+800
| +16% | +$40.4K | 0.13% | 85 |
|
|
2013
Q4 | $261K | Sell |
4,941
-1,900
| -28% | -$93.4K | 0.11% | 88 |
|
|
2013
Q3 | $306K | Sell |
6,841
-1,050
| -13% | -$46.5K | 0.13% | 80 |
|
|
2013
Q2 | $326K | Buy |
+7,891
| New | +$345K | 0.14% | 82 |
|
Other funds holding ABBV
HeadInvest LLC's ABBV Position: Q2 2026 in Review
HeadInvest LLC increased its AbbVie (ABBV) stake by 0.59% in Q2 2026, buying an estimated $11.8K and bringing the position to 9,300 shares worth $2.34M. The position accounts for 0.44% of the portfolio, ranked #63.
HeadInvest LLC first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- HeadInvest LLC held 9,300 shares of AbbVie worth $2.34M as of Q2 2026.
- HeadInvest LLC bought 55 AbbVie shares in Q2 2026, an estimated $11.8K.
- AbbVie made up 0.44% of HeadInvest LLC's portfolio in Q2 2026, its #63 holding.
- HeadInvest LLC first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on HeadInvest LLC's 13F filing for Q2 2026, filed 14 Aug 2026.